Blood Bank Market by Product Type (Whole Blood, Red Blood Cells, Platelets, Plasma, and White Blood Cells), Function (Collection, Processing, Testing, Storage, and Transportation), Bank Type (Private and Public), and End User (Hospital, Ambulatory Surgery Centers, Pharmaceutical Companies, Clinics & Nursing Homes, and Others): Global Opportunity Analysis and Industry Forecast, 20202027
- Published Date: 2020-11-18
- Report ID: 18189
- Pages: 245
-
Format:
The global blood bank market was valued at $13.85 billion in 2019 and is expected to reach $21.86 billion by 2027, registering a CAGR of 5.7% from 2020 to 2027.
A blood bank is a non-profit organization that engages in all the operations such as collection, processing, testing, storage, and distribution of blood and blood components drawn from donors. A blood bank can be a separate free-standing organization or operates as a part of a hospital. In addition, a blood bank provides safe or disease-free blood for transfusion to save a patient's life and curb the complications that can arise due to severe blood loss.
Blood banks have witnessed an increase in demand, owing to high prevalence of hematological diseases and rise in number of accidental cases across the world. In addition, growth in the geriatric population who is prone to blood disorders and high demand for blood transfusion supplement the market growth. However, wastage of the donated blood and stringent rules & regulations are anticipated to hamper the market growth. On the contrary, blood transfusion in emerging nations is expected to offer significant profitable opportunities for the market players.
The global blood bank market is segmented based on product type, function, bank type, end user, and region. Based on product type, the market is classified as whole blood, red blood cell, platelets, plasma, and white blood cell. The function segment studies collection, processing, testing, storage, and transportation. Based on bank type, the market is segmented into private and public. Depending on end user, the market is classified into hospital, ambulatory surgery center, pharmaceutical companies, clinics & nursing homes, and others. Based on region, the market is studied across North America, Europe, Asia-Pacific, and LAMEA.
KEY BENEFITS FOR STAKEHOLDERS
This report provides a detailed quantitative analysis of the current market trends and future estimations from 2020 to 2027, which assists in identifying the prevailing market opportunities.
An in-depth analysis of various regions is anticipated to provide a detailed understanding of the current trends to enable stakeholders formulate region-specific plans.
A comprehensive analysis of the factors that drive and restrain the growth of the global blood bank market is provided.
The key regulatory guidelines for the blood bank market are critically dealt with according to geography.
An extensive analysis of various regions provides insights that allow companies to strategically plan their business moves.
KEY MARKET SEGMENTS
By Product Type
o Whole blood
o Red Blood Cell
o Platelet
o Plasma
o White Blood Cell
By Function
o Collection
o Processing
o Testing
o Storage
o Transportation
By Bank Type
o Private
o Public
By End User
o Hospital
o Ambulatory Surgery Centers
o Pharmaceutical Companies
o Clinics & Nursing homes
o Others
By Region
o North America
U.S.
Canada
Mexico
o Europe
Germany
France
UK
Rest of Europe
o Asia-Pacific
Australia
Japan
India
China
Rest of Asia-Pacific
o LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
KEY MARKET PLAYERS
The American Red Cross
Vitalant
New York Blood Centre
Australian Red Cross
Japan Red Cross Society
American Association of Blood Banks
America's Blood Centers
Canadian Blood Services
Sanquin Blood Supply Foundation
Blood Bank of Alaska
CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.3.1.List of key players profiled in the report
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.1.1.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Market share analysis, 2019
3.4.Porters five forces analysis
3.5.Market dynamics
3.5.1.Drivers
3.5.1.1.High prevalence of hematologic diseases
3.5.1.2.Rise in accidents
3.5.1.3.Growth in geriatric population
3.5.2.Restraints
3.5.2.1.Wastage of donated blood
3.5.2.2.Stringent rules and regulations
3.5.3.Opportunity
3.5.3.1.Blood transfusion in emerging nations
3.6.Pricing Analysis
CHAPTER 4:BLOOD BANK MARKET, BY PRODUCT TYPE
4.1.Overview
4.1.1.Market size and forecast
4.2.Whole blood
4.2.1.Key market trends and growth opportunities
4.2.2.Market size and forecast
4.2.3.Market analysis, by country
4.3.Red blood Cell
4.3.1.Key market trends and growth opportunities
4.3.2.Market size and forecast
4.3.3.Market analysis, by country
4.4.Platelet
4.4.1.Key market trends and growth opportunities
4.4.2.Market size and forecast
4.4.3.Market analysis, by country
4.5.Plasma
4.5.1.Key market trends and growth opportunities
4.5.2.Market size and forecast
4.5.3.Market analysis, by country
4.6.White blood cell
4.6.1.Key market trends and growth opportunities
4.6.2.Market size and forecast
4.6.3.Market analysis, by country
CHAPTER 5:BLOOD BANK MARKET, BY FUNCTION
5.1.Overview
5.1.1.Market size and forecast
5.2.Collection
5.2.1.Market size and forecast
5.2.2.Market analysis, by country
5.3.Processing
5.3.1.Market size and forecast
5.3.2.Market analysis, by country
5.4.Testing
5.4.1.Market size and forecast
5.4.2.Market analysis, by country
5.5.Storage
5.5.1.Market size and forecast
5.5.2.Market analysis, by country
5.6.Transportation
5.6.1.Market size and forecast
5.6.2.Market analysis, by country
CHAPTER 6:BLOOD BANK MARKET, BY BANK TYPE
6.1.Overview
6.1.1.Market size and forecast
6.2.Private
6.2.1.Market size and forecast
6.2.2.Market analysis, by country
6.3.Public
6.3.1.Market size and forecast
6.3.2.Market analysis, by country
CHAPTER 7:BLOOD BANK MARKET, BY END USER
7.1.Overview
7.1.1.Market size and forecast
7.2.Hospital
7.2.1.Market size and forecast
7.2.2.Market analysis, by country
7.3.Ambulatory surgery centers
7.3.1.Market size and forecast
7.3.2.Market analysis, by country
7.4.Pharmaceutical companies
7.4.1.Market size and forecast
7.4.2.Market analysis, by country
7.5.Clinics & Nursing homes
7.5.1.Market size and forecast
7.5.2.Market analysis, by country
7.6.Others
7.6.1.Market size and forecast
7.6.2.Market analysis, by country
CHAPTER 8:BLOOD BANK MARKET, BY REGION
8.1.Overview
8.1.1.Market size and forecast
8.2.North America
8.2.1.Key market trends and opportunities
8.2.2.North America blood bank market, by country
8.2.2.1.U.S. blood bank market, by product type
8.2.2.2.U.S. blood bank market, by function
8.2.2.3.U.S. blood bank market by bank type
8.2.2.4.U.S. blood bank market, by end user
8.2.2.5.Canada blood bank market, by product type
8.2.2.6.Canada blood bank market, by function
8.2.2.7.Canada blood bank market by bank type
8.2.2.8.Canada blood bank market, by end user
8.2.2.9.Mexico blood bank market, by product type
8.2.2.10.Mexico blood bank market, by function
8.2.2.11.Mexico blood bank market by bank type
8.2.2.12.Mexico blood bank market, by end user
8.2.3.North America blood bank market, by product type
8.2.4.North America blood bank market, by function
8.2.5.North America blood bank market, by bank type
8.2.6.North America blood bank market, by end user
8.3.Europe
8.3.1.Key market trends and opportunities
8.3.2.Europe blood bank market, by country
8.3.2.1.Germany blood bank market, by product type
8.3.2.2.Germany blood bank market, by function
8.3.2.3.Germany blood bank market by bank type
8.3.2.4.Germany blood bank market, by end user
8.3.2.5.France blood bank market, by product type
8.3.2.6.France blood bank market, by function
8.3.2.7.France blood bank market by bank type
8.3.2.8.France blood bank market, by end user
8.3.2.9.UK blood bank market, by product type
8.3.2.10.UK blood bank market, by function
8.3.2.11.UK blood bank market by bank type
8.3.2.12.UK blood bank market, by end user
8.3.2.13.Rest of Europe blood bank market, by product type
8.3.2.14.Rest of Europe blood bank market, by function
8.3.2.15.Rest of Europe blood bank market by bank type
8.3.2.16.Rest of Europe blood bank market, by end user
8.3.3.Europe blood bank market, by product type
8.3.4.Europe blood bank market, by function
8.3.5.Europe blood bank market, by bank type
8.3.6.Europe blood bank market, by end user
8.4.Asia-pacific
8.4.1.Key market trends and opportunities
8.4.2.Asia-Pacific blood bank market, by country
8.4.2.1.Australia blood bank market, by product type
8.4.2.2.Australia blood bank market, by function
8.4.2.3.Australia blood bank market by bank type
8.4.2.4.Australia blood bank market, by end user
8.4.2.5.Japan blood bank market, by product type
8.4.2.6.Japan blood bank market, by function
8.4.2.7.Japan blood bank market by bank type
8.4.2.8.Japan blood bank market, by end user
8.4.2.9.India blood bank market, by product type
8.4.2.10.India blood bank market, by function
8.4.2.11.India blood bank market by bank type
8.4.2.12.India blood bank market, by end user
8.4.2.13.China blood bank market, by product type
8.4.2.14.China blood bank market, by function
8.4.2.15.China blood bank market by bank type
8.4.2.16.China blood bank market, by end user
8.4.2.17.Rest of Asia-Pacific blood bank market, by product type
8.4.2.18.Rest of Asia-Pacific blood bank market, by function
8.4.2.19.Rest of Asia-Pacific blood bank market by bank type
8.4.2.20.Rest of Asia-Pacific blood bank market, by end user
8.4.3.Asia-Pacific blood bank market, by product type
8.4.4.Asia-Pacific blood bank market, by function
8.4.5.Asia-Pacific blood bank market, by bank type
8.4.6.Asia-Pacific blood bank market, by end user
8.5.LAMEA
8.5.1.Key market trends and opportunities
8.5.2.LAMEA blood bank market, by country
8.5.2.1.Brazil blood bank market, by product type
8.5.2.2.Brazil blood bank market, by function
8.5.2.3.Brazil blood bank market by bank type
8.5.2.4.Brazil blood bank market, by end user
8.5.2.5.Saudi Arabia blood bank market, by product type
8.5.2.6.Saudi Arabia blood bank market, by function
8.5.2.7.Saudi Arabia blood bank market by bank type
8.5.2.8.Saudi Arabia blood bank market, by end user
8.5.2.9.South Africa blood bank market, by product type
8.5.2.10.South Africa blood bank market, by function
8.5.2.11.South Africa blood bank market by bank type
8.5.2.12.South Africa blood bank market, by end user
8.5.2.13.Rest of LAMEA blood bank market, by product type
8.5.2.14.Rest of LAMEA blood bank market, by function
8.5.2.15.Rest of LAMEA blood bank market by bank type
8.5.2.16.Rest of LAMEA blood bank market, by end user
8.5.3.LAMEA blood bank market, by product type
8.5.4.LAMEA blood bank market, by function
8.5.5.LAMEA blood bank market, by bank type
8.5.6.LAMEA blood bank market, by end user
CHAPTER 9:COMPANY PROFILES
9.1.AMERICAN ASSOCIATION OF BLOOD BANKS
9.1.1.Company overview
9.1.2.Company snapshot
9.1.3.Operating business segments
9.1.4.Business performance
9.2.AMERICA'S BLOOD CENTERS
9.2.1.Company overview
9.2.2.Company snapshot
9.2.3.Operating business segments
9.2.4.Business performance
9.3.AUSTRALIAN RED CROSS SOCIETY
9.3.1.Company overview
9.3.2.Company snapshot
9.3.3.Operating business segments
9.3.4.Business performance
9.4.BLOOD BANK OF ALASKA
9.4.1.Company overview
9.4.2.Company snapshot
9.4.3.Operating business segments
9.5.CANADIAN BLOOD SERVICES
9.5.1.Company overview
9.5.2.Company snapshot
9.5.3.Operating business segments
9.5.4.Business performance
9.6.JAPANESE RED CROSS SOCIETY
9.6.1.Company overview
9.6.2.Company snapshot
9.6.3.Operating business segments
9.7.NEW YORK BLOOD CENTRE
9.7.1.Company overview
9.7.2.Company snapshot
9.7.3.Operating business segments
9.8.SANQUIN BLOOD SUPPLY FOUNDATION
9.8.1.Company overview
9.8.2.Company snapshot
9.8.3.Operating business segments
9.8.4.Business performance
9.9.THE AMERICAN RED CROSS
9.9.1.Company overview
9.9.2.Company snapshot
9.9.3.Operating business segments
9.9.4.Business performance
9.10.VITALANT
9.10.1.Company overview
9.10.2.Company snapshot
9.10.3.Operating business segments
9.10.4.Business performance
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
